Table 3.
Predictors | β | SE | HR | 95% CI | p value |
---|---|---|---|---|---|
Gender | 0.19 | ||||
Male | Ref | ||||
Female | − 0.3 | 0.2 | 0.7 | 0.5–1.2 | 0.19 |
Age at diagnosis | − 0.1 | 0.02 | 0.9 | 0.92–0.98 | 0.004 |
Types of professional qualification | 0.01 | ||||
None | Ref | ||||
Vocational training/company training) | 0.2 | 0.4 | 1.2 | 0.5–2.7 | 0.72 |
Vocational school (master craftsman/technical school, technical academy) | − 0.1 | 0.5 | 0.9 | 0.3–2.4 | 0.79 |
University (University/University of Applied Sciences/Engineering School/University of Cooperative Education) | 0.8 | 0.5 | 2.2 | 0.8–5.8 | 0.12 |
Disease status | 0.02 | ||||
Progression | Ref | ||||
Not detectable | 1.7 | 0.7 | 5.4 | 1.5–19.8 | 0.01 |
Remission | 1.7 | 0.8 | 5.5 | 1.2–26.2 | 0.03 |
Stable | 1.7 | 0.7 | 5.6 | 1.5–20.3 | 0.01 |
Fatigue | 0.06 | ||||
Less | Ref | ||||
Medium | − 0.2 | 0.3 | 0.8 | 0.5–1.4 | 0.41 |
High | − 0.7 | 0.3 | 0.5 | 0.3–0.9 | 0.02 |
Use of social service counseling | 0.06 | ||||
Not used | Ref | ||||
Used | 0.5 | 0.2 | 1.6 | 1.002–2.546 | 0.048 |
Monthly household net income | 0.21 | ||||
< 1000€ | Ref | ||||
1000–2000€ | − 0.5 | 0.4 | 0.6 | 0.3–1.3 | 0.20 |
2000–3000€ | − 0.2 | 0.4 | 0.9 | 0.4–1.9 | 0.7 |
3000–4000€ | 0.4 | 0.4 | 1.4 | 0.6–3.4 | 0.42 |
> 4000€ | − 0.04 | 0.5 | 0.9 | 0.4–2.4 | 0.92 |
Treatment type | 0.01 | ||||
Surgery only | Ref | ||||
Surgery + ST ± RT | − 1.2 | 0.4 | 0.3 | 0.1–0.6 | 0.0004 |
RT only/ST only | − 1.2 | 0.6 | 0.3 | 0.1–0.9 | 0.04 |
RT + ST | − 1.4 | 0.5 | 0.2 | 0.1–0.7 | 0.01 |
UICC stage at diagnosis | 0.05 | ||||
Stage I | Ref | ||||
Stage II | 0.7 | 0.3 | 1.9 | 0.9–3.8 | 0.06 |
Stage III | − 0.2 | 0.4 | 0.8 | 0.4–1.9 | 0.65 |
Stage IV | − 0.1 | 0.5 | 0.9 | 0.3–2.3 | 0.79 |
Time since last therapy | 0.13 | ||||
Currently in treatment or < 1 month ago | Ref | ||||
1 < 12 month ago | − 1.2 | 0.6 | 0.3 | 0.1–0.9 | 0.04 |
≥ 12 months ago | − 0.8 | 0.4 | 0.4 | 0.2–0.9 | 0.05 |
**Unknown categories are not reported
SE standard error, HR hazard ratio, CI confidence interval, UICC International Union Against Cancer, ST systemic therapy, RT radiotherapy